Novo Holdings A/S - Jun 23, 2023 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (RPHM)

Role: 10%+ Owner
Signature: /s/ Barbara Fiorini Due, General Counsel, Finance & Operations of Novo Holdings A/S
Stock symbol: RPHM
Transactions as of: Jun 23, 2023
Transactions value $: -$709,740
Form type: 4
Date filed: 6/23/2023, 07:15 PM
Previous filing: Jun 23, 2023
Next filing: Jun 28, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPHM	Common Stock	Sale	-$710K	-100K	-2.92%	$7.10	3.33M	Jun 23, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Novo Holdings A/S is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.93 to $7.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.93 to $7.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.